國立高雄大學圖資館 |

Language: English

Back

Behavioral pharmacology of nxytocin

Grinevich, Valery.

Behavioral pharmacology of nxytocin

Record Type:	Electronic resources : Monograph/item
Title/Author:	Behavioral pharmacology of nxytocinedited by Rene Hurlemann, Valery Grinevich.
other author:	Hurlemann, Rene.
Published:	Cham :Springer International Publishing :2018.
Description:	ix, 593 p. :digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Oxytocin.
Online resource:	http://dx.doi.org/10.1007/978-3-319-63739-6
ISBN:	9783319637396$q(electronic bk.)

Behavioral pharmacology of nxytocin
Behavioral pharmacology of nxytocin[electronic resource] /edited by Rene Hurlemann, Valery Grinevich. - Cham :Springer International Publishing :2018. - ix, 593 p. :digital ;24 cm. - Current topics in behavioral neurosciences,v.351866-3370 ;. - Current topics in behavioral neurosciences ;9..

Preface -- Part 1 Human Research -- Oxytocin Administration in Humans. Oxytocin & Human Social Perception. Oxytocin & Human Social Cognition. Oxytocin & Human Pair Bonding. Oxytocin & Human Parenting. Oxytocin & Autism Spectrum Disorders. Oxytocin & Anxiety Disorders. Oxytocin & Borderline Personality Disorder. Oxytocin & Schizophrenia Spectrum Disorders. Oxytocin & Prader-Willi Syndrome. Translating oxytocin research into therapeutics: a precision medicine approach -- Part 2 Animal Research -- Oxytocin Receptor Signaling. Oxytocin & Steroid Action. Oxytocin & Olfaction. Oxytocin & Social Behavior of Primates. Oxytocin & Parental Behavior. Oxytocin & Pain. Oxytocin & Alcohol Abuse. Oxytocin & Autism Spectrum Disorders. Genetics & Early Life Development of the oxytocin system. Oxytocin, Pair-Bonding and Partner Loss. Oxytocin & Cortical Function.

This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of "precision medicine" approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.

ISBN: 9783319637396$q(electronic bk.)

Standard No.: 10.1007/978-3-319-63739-6doiSubjects--Topical Terms:

820521
Oxytocin.

LC Class. No.: QP572.O9 / B443 2018

Dewey Class. No.: 615.782

Behavioral pharmacology of nxytocin
LDR:03363nmm a2200325 a 4500 001 542662
003 DE-He213
005 20190122132332.0
006 m d
007 cr nn 008maaau
008 190411s2018 gw s 0 eng d
020 $a 9783319637396$q(electronic bk.)
020 $a 9783319637389$q(paper)
024 7 $a 10.1007/978-3-319-63739-6 $2 doi
035 $a 978-3-319-63739-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QP572.O9 $b B443 2018
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 615.782 $2 23
090 $a QP572.O9 $b B419 2018
245 0 0 $a Behavioral pharmacology of nxytocin $h [electronic resource] / $c edited by Rene Hurlemann, Valery Grinevich.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a ix, 593 p. : $b digital ; $c 24 cm.
490 1 $a Current topics in behavioral neurosciences, $x 1866-3370 ; $v v.35
505 0 $a Preface -- Part 1 Human Research -- Oxytocin Administration in Humans. Oxytocin & Human Social Perception. Oxytocin & Human Social Cognition. Oxytocin & Human Pair Bonding. Oxytocin & Human Parenting. Oxytocin & Autism Spectrum Disorders. Oxytocin & Anxiety Disorders. Oxytocin & Borderline Personality Disorder. Oxytocin & Schizophrenia Spectrum Disorders. Oxytocin & Prader-Willi Syndrome. Translating oxytocin research into therapeutics: a precision medicine approach -- Part 2 Animal Research -- Oxytocin Receptor Signaling. Oxytocin & Steroid Action. Oxytocin & Olfaction. Oxytocin & Social Behavior of Primates. Oxytocin & Parental Behavior. Oxytocin & Pain. Oxytocin & Alcohol Abuse. Oxytocin & Autism Spectrum Disorders. Genetics & Early Life Development of the oxytocin system. Oxytocin, Pair-Bonding and Partner Loss. Oxytocin & Cortical Function.
520 $a This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of "precision medicine" approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.
650 0 $a Oxytocin. $3 820521
650 0 $a Psychopharmacology. $3 252258
650 0 $a Neuropeptides. $3 194140
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Neurosciences. $3 211508
650 2 4 $a Psychiatry. $3 201470
650 2 4 $a Behavioral Sciences. $3 704387
650 2 4 $a Endocrinology. $3 196517
700 1 $a Hurlemann, Rene. $3 820519
700 1 $a Grinevich, Valery. $3 820520
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Current topics in behavioral neurosciences ; $v 9. $3 559431
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-63739-6
950 $a Biomedical and Life Sciences (Springer-11642)